CAS: 119124-53-7; 3-Methyltetrahydropyran-4-One

该化合物是一个含有分子式C6H10O2的圆形酮,其特点是在3位置用六人组成的氧烷环替换为3位置的甲基组,在4位置用碳基组.该化合物对有机合成感兴趣,因为它具有作为酮的活性,能够促成诸如核生殖毒性增加或减少等变异.其结构框架也使它成为药物,香料或农用化学品的潜在中间体.同一环内存在一种六人组成的氧烷环和一种四位置的甲基组,在进一步衍生方面具有多功能.由于易燃性和潜在刺激性,建议谨慎处理.

英文名称3-Methyltetrahydropyran-4-One
中文名称3-甲基四氢吡喃-4-酮
IUPAC名称3-methyltetrahydro-4H-pyran-4-one
其它别名四氢-3-甲基-4H-吡喃-4-酮
CAS编号119124-53-7
MFCD编号:MFCD13193744
EINECS号:818-650-6
分子式:C6H10O2
分子量:114.14
产品CID: 253994
产品分类有机原料→分子砌块→脂肪杂环类化合物→四氢吡喃类化合物

相似结构搜索
InChIKey: PGPWMORFOPRGCA-UHFFFAOYSA-N
InChI=1/C6H10O2/c1-5-4-8-3-2-6(5)7/h5H,2-4H2,1H3…
计算化学: 氢键受体数2.0氢键供体数0.0可旋转键数0.0

相似化合物

3174-65-0 2198055-93-3 2306253-03-0

MSDS等安全信息

GHS符号GHS07
危险类别易燃液体类别3
特定目标器官毒性 - 单次接触类别3
皮肤腐蚀/刺激类别2
严重眼刺激类别2A
警示词Warning
危险描述H226 |易燃液体和蒸气.
H335 |可能引起呼吸道刺激.
H315 |造成皮肤刺激.
H319 |造成严重眼刺激.
防范说明P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501

欧盟法规

C&L通报

合成工艺路线路线简述

海关参考信息

2905121000-正丙醇
2909110000-乙醚
2912110000-甲醛
2912120000-乙醛
💡 提示：海关信息按照顺序优先匹配，如需确认的海关信息，请参考相关资料。
详情请参考：📖 海关编码查询和海关进出口税则

专利信息

专利号:US-2024400552-A1
优先权日:2016-11-11
标题 :Heterocyclic modulators of lipid synthesis
发明人：BUCKLEY DOUGLAS I; DUKE GREGORY; WAGMAN ALLAN S; EVANCHIK MARC; MCDOWELL ROBERT S
权利人:SAGIMET BIOSCIENCES INC
摘要:Compounds that are fatty acid synthesis modulators are provided. The compounds may be used to treat disorders characterized by dysregulation of the fatty acid synthase function by modulating the function and/or the fatty acid synthase pathway. Methods are provided for treating such disorders including viral infections, such as hepatitis C infection, cancer and metabolic disorders, such as non-alcoholic steatohepatitis (NASH).

专利号:US-11622968-B2
优先权日:2011-03-08
标题:Heterocyclic modulators of lipid synthesis
发明人：BUCKLEY DOUGLAS; DUKE GREGORY; WAGMAN ALLAN S; EVANCHIK MARC; MCDOWELL ROBERT S
权利人:SAGIMET BIOSCIENCES INC
摘要:Compounds that are fatty acid synthesis modulators are provided. The compounds may be used to treat disorders characterized by disregulation of the fatty acid synthase function by modulating the function and/or the fatty acid synthase pathway. Methods are provided for treating such disorders including viral infections, such as hepatitis C infection, cancer and metabolic disorders, such as non-alcoholic steatohepatitis (NASH).

专利号:US-11034690-B2
优先权日:2016-11-11
标题:Heterocyclic modulators of lipid synthesis
发明人：BUCKLEY DOUGLAS I; DUKE GREGORY; WAGMAN ALLAN S; EVANCHIK MARC; MCDOWELL ROBERT S
权利人:SAGIMET BIOSCIENCES INC; SAGINIET BIOSCIENCES INC
摘要:Compounds that are fatty acid synthesis modulators are provided. The compounds may be used to treat disorders characterized by disregulation of the fatty acid synthase function by modulating the function and/or the fatty acid synthase pathway. Methods are provided for treating such disorders including viral infections, such as hepatitis C infection, cancer and metabolic disorders, such as non-alcoholic steatohepatitis (NASH).

专利号:US-9809591-B2
优先权日:2011-03-08
标题 :Heterocyclic modulators of lipid synthesis
发明人：OSLOB JOHAN D; MCDOWELL ROBERT S; JOHNSON RUSSELL; YANG HANBIAO; EVANCHIK MARC; ZAHARIA CRISTIANA A; CAI HAIYING; HU LILY W
权利人:3-V BIOSCIENCES INC
摘要:Compounds that are fatty acid synthesis modulators are provided. The compounds may be used to treat disorders characterized by disregulation of the fatty acid synthase function by modulating the function and/or the fatty acid synthase pathway. Methods are provided for treating such disorders including viral infections, such as hepatitis C infection, cancer and metabolic disorders.

专利号:US-2019308969-A1
优先权日:2016-11-11
标题 :Heterocyclic modulators of lipid synthesis

专利号:US-2022296605-A1
优先权日:2011-03-08
标题 :Heterocyclic modulators of lipid synthesis